...
首页> 外文期刊>Tumour biology : >Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways
【24h】

Ataxia-telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways

机译:共济失调毛细血管扩张组D互补基因(ATDC)上调基质金属蛋白酶9(MMP-9)通过激活ERK和JNK途径促进肺癌细胞的侵袭

获取原文
获取原文并翻译 | 示例

摘要

Although the expression pattern and biological functions of ataxia-telangiectasia group D complementing gene (ATDC) had been implicated in several types of cancer, the roles and potential mechanisms of ATDC in lung cancer cell invasion are still ambiguous. In this study, we used gain- and loss-of-function analyses to explore the roles and potential mechanisms of ATDC in lung cancer cell invasion. siRNA knockdown of ATDC impaired cell invasion in A549 and H1299 cell lines, and its overexpression promoted cell invasion in HBE cell line. ATDC may contribute to the invasive ability of lung cancer cells by promoting the expression of invasion-related matrix metalloproteinase 9 (MMP-9). In addition, ATDC increased activating protein 1 (AP-1) reporter luciferase activity and the protein and mRNA levels of c-Jun and c-Fos. We further demonstrated that the roles of ATDC on cell invasion, MMP-9 upregulation, and AP-1 activation were dependent on extracellular signal-regulated protein kinase (ERK) and c-Jun N-terminal kinase (JNK) pathway activation, and ERK inhibitor U0126 or JNK inhibitor SP600125 blocked these effects of ATDC. These results suggested that ATDC upregulates MMP-9 to promote lung cancer cell invasion by activating ERK and JNK pathways.
机译:尽管共济失调-毛细血管扩张D组互补基因(ATDC)的表达模式和生物学功能与多种类型的癌症有关,但ATDC在肺癌细胞侵袭中的作用和潜在机制仍不清楚。在这项研究中,我们使用功能获得和功能丧失分析来探索ATDC在肺癌细胞侵袭中的作用和潜在机制。 ATDC的siRNA敲低损害了A549和H1299细胞系的细胞侵袭,其过表达促进了HBE细胞系的细胞侵袭。 ATDC可能通过促进侵袭相关基质金属蛋白酶9(MMP-9)的表达来促进肺癌细胞的侵袭能力。此外,ATDC增加了活化蛋白1(AP-1)报告荧光素酶活性以及c-Jun和c-Fos的蛋白和mRNA水平。我们进一步证明了ATDC在细胞侵袭,MMP-9上调和AP-1激活中的作用取决于细胞外信号调节蛋白激酶(ERK)和c-Jun N端激酶(JNK)途径激活和ERK抑制剂U0126或JNK抑制剂SP600125阻断了ATDC的这些作用。这些结果表明,ATDC通过激活ERK和JNK途径上调MMP-9从而促进肺癌细胞的侵袭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号